| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TCRR | Common Stock | Award | $6.02K | +422 | +10.33% | $14.26* | 4.51K | Aug 31, 2021 | Direct | F2, F3 |
| transaction | TCRR | Common Stock | Options Exercise | $130K | +175K | +3882.85% | $0.74 | 180K | Dec 9, 2021 | Direct | |
| holding | TCRR | Common Stock | 84.5K | Aug 31, 2021 | See Footnote | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TCRR | Stock Option (Right to Buy) | Options Exercise | $125K | +169K | $0.74 | 0 | Dec 10, 2021 | Common Stock | 169K | $0.74 | Direct | F4 | |
| transaction | TCRR | Stock Option (Right to Buy) | Options Exercise | $4.4K | +5.95K | +4.5% | $0.74 | 138K | Dec 10, 2021 | Common Stock | 5.95K | $0.74 | Direct | F5 |
| transaction | TCRR | Stock Option (Right to Buy) | Award | $0 | +306K | $0.00 | 306K | Dec 9, 2021 | Common Stock | 306K | $5.21 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | Consists of 84,527 shares of common stock held by Dr. Garry Menzel, as Trustee of the Garry E. Menzel and Mary E. Henshall Family Trust, under instrument of trust dated July 29, 2010. Dr. Menzel is the trustee of the Garry E. Menzel and Mary E. Henshall Family Trust and may be deemed to beneficially own these securities. |
| F2 | The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the issuer's 2018 Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of March 1, 2021 through August 31, 2021. This transaction is exempt under Rule 16b-3(c). |
| F3 | In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on August 31, 2021. |
| F4 | The Reporting Person was granted an option to purchase 253,581 shares on December 13, 2016. 84,527 of such options were previously exercised. 25% of this option vested and became exercisable on October 17, 2017, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. |
| F5 | 25% of this option vested and became exercisable on December 6, 2018, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. |
| F6 | 25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter |